📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
0 articles
AVG GRADE
HIGH
score: 0.50
SENTIMENT
NEUTRAL
TOTAL VIEWS
11
ADIL Latest News & AI Sentiment Analysis
0 articles · Grade: HIGH · Real-time AI-graded coverage
RECENT COVERAGE · 4 ARTICLES
Adial Pharmaceuticals Expands Executive Leadership Team and Closes PIPE Financing
Adial Pharmaceuticals (ADIL) has announced two concurrent corporate developments: the closing of a business combination with Azora...
Top Biotech Gainers: VRXA Begins A New Chapter, ADIL Opens Wallet, PGEN, PCSA On Watch...
ADIL announced the acquisition of Azora Therapeutics, a strategic move designed to expand its clinical pipeline and enhance its...
Adial Pharmaceuticals acquires Azora Therapeutics, secures up to $64M financing
Adial Pharmaceuticals announced an acquisition of Azora Therapeutics coupled with secured financing of up to $64M, signaling capital...
Adial Pharmaceuticals Announces Acquisition of Azora Therapeutics and up to $64 Million Financing
Adial Pharmaceuticals has announced the acquisition of Azora Therapeutics paired with a concurrent private placement raising up to $64...
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice